L710-3039 Screening compound: 4-(5-{2-[4-(4-fluorophenyl)piperazine-1-carbonyl]phenyl}-1,3-oxazole-4-carbonyl)morpholine

L710-3039 Screening compound: 4-(5-{2-[4-(4-fluorophenyl)piperazine-1-carbonyl]phenyl}-1,3-oxazole-4-carbonyl)morpholine
L710-3039 Screening compound: 4-(5-{2-[4-(4-fluorophenyl)piperazine-1-carbonyl]phenyl}-1,3-oxazole-4-carbonyl)morpholine alternative view

Chemical Structure Depiction of ChemDiv screening compound L710-3039
4-(5-{2-[4-(4-fluorophenyl)piperazine-1-carbonyl]phenyl}-1,3-oxazole-4-carbonyl)morpholine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L710-3039

Molecular Formula

C25H25FN4O4 (C25 H25 FN4 O4)

Compound Name

4-(5-{2-[4-(4-fluorophenyl)piperazine-1-carbonyl]phenyl}-1,3-oxazole-4-carbonyl)morpholine

IUPAC name

4-(5-{2-[4-(4-fluorophenyl)piperazine-1-carbonyl]phenyl}-13-oxazole-4-carbonyl)morpholine

SMILES

O=C(c1c(-c(cccc2)c2C(N(CC2)CCN2c(cc2)ccc2F)=O)ocn1)N1CCOCC1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

464.5

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.130

Distribution Coefficient, logD

2.130

Water Solubility, LogSw

-2.73

Polar Surface Area

63.540

Acid Dissociation Constant (pKa)

28.00

Base Dissociation Constant (pKb)

1.23

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.00

L710-3039 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • GPCR
  • Kinases
Mechanism of action:
  • Receptor's ligands
  • PPI modulators

References: we are preparing a list of scientific research reports with L710-3039 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L710-3039?
Check Price and Availability of L710-3039, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L710-3039 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L710-3039
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L710-3039
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L710-3039 available by request